避けられないものに向き合う：研究所開発テストの規制要件に備えること。
PMID: 29659675 ·
R, i, t, a, , D, ', A, n, g, e, l, o, ;, , R, o, n, a, l, d, , W, e, i, s, s, ;, , D, a, v, i, d, , W, o, l, f, e, ;, , R, a, t, n, a, , C, h, i, n, n, a, m, ;, , A, l, p, e, r, , M, u, r, a, t, ;, , J, u, l, i, a, , G, l, u, e, s, i, n, g, ;, , T, o, n, i, , S, o, m, e, r, s
広告
抄録
We introduce regulatory terms, definitions, and the Quality System Regulation as proposed by the US Food and Drug Administration in the 2014 draft guidance entitled Framework for Regulatory Oversight of Laboratory Developed Tests and explore medical device requirements applicable to a laboratory environment to design, develop, and validate laboratory developed tests (LDTs). We performed nine interviews with laboratory professionals to explore concerns and challenges regarding the draft, translat
広告
公式ソース
PubMedで見る →データはPubMed / NCBIから取得しています。全文および最新情報は必ず公式記録をご確認ください。